Health & Biotech
ASX Health Stocks: Anteris successfully implants aortic valve, MGC Pharma a step closer to FDA submission
ScoPo’s Powerplays: ASX health stock fall but hold onto your hat for reporting season
Weed Week: Mastercard says NO to cannabis transactions, as New York becomes the happening place for weed
Incannex’s subsidiary Clarion Clinics prepares to take first clients for psychedelic treatment
ASX Health Stocks: Althea says its cannabis beverage could generate $5m of sales in Canada
ASX Health Stocks: Cyclopharm confident after US FDA inspection; Anteris a step closer to FDA approval
Preliminary evidence for MPL activity enables PharmAust to commence planning a Phase 2 trial in motor neurone disease
Melodiol has a new name and big plans to scale its global cannabis and psychedelics market share
ASX Health Stocks: Recce Pharma jumps 20pc after saying its gel could heal antibiotic-resistant infections
Dimerix achieves successful second key review for its Phase 3 FSGS kidney disease trial
Once banned in Australia, kava’s demand could go global according to ASX-listed The Calmer Co
ASX Health Stocks: Firebrick achieves primary endpoint in Phase 2; Memphasys surges 20pc on Japan deal
ScoPo’s Powerplays: Mesoblast sinks Health sector, and how to live 24 years longer
ASX Health Stocks: Mesoblast crashes 54pc after FDA says it needs more data for approval
Nova Eye’s new iTrack Advance eyes broader market as improves key glaucoma procedure
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback
Advance US sales of Nova’s iTrack glaucoma surgery device hits US$2.2m
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
